The panelists agreed that the next wave of healthcare innovation will not be driven by technology alone—it will require collaboration across sectors. The future of healthcare is not just about adding ...

AstraZeneca has agreed to acquire Belgian in vivo cell therapy biotech EsoBiotec, strengthening its position in the emerging field of treatments that can reprogramme immune cells inside patients' ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stands ...

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. I was a bit worried last week’s ...

As Sage Therapeutics Inc. contemplates its path forward after rejecting a buyout offer from Biogen, its top executive ...

There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

Large mergers and acquisitions in the Indian pharmaceutical market are unlikely soon due to various uncertainties, says GV ...

In a recent webinar conducted by IQVIA and pharmaphorum, several experts gathered to give their views on the current state of UK biotech and what the future might look like. Steve Bates ...

The biotech segment, in particular, remains a source of concern due to limited visibility on future bookings and the potential impact of broader funding weaknesses in the sector. The prolonged sales ...

Scotland’s rich culinary heritage ​is vital for the country’s economy – but it needs to be future-proofed, writes Dr Liz ...